1. Home
  2. BIOA vs CBFV Comparison

BIOA vs CBFV Comparison

Compare BIOA & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIOA
  • CBFV
  • Stock Information
  • Founded
  • BIOA 2015
  • CBFV 1901
  • Country
  • BIOA United States
  • CBFV United States
  • Employees
  • BIOA N/A
  • CBFV N/A
  • Industry
  • BIOA Biotechnology: Pharmaceutical Preparations
  • CBFV Major Banks
  • Sector
  • BIOA Health Care
  • CBFV Finance
  • Exchange
  • BIOA Nasdaq
  • CBFV Nasdaq
  • Market Cap
  • BIOA 162.0M
  • CBFV 148.0M
  • IPO Year
  • BIOA 2024
  • CBFV N/A
  • Fundamental
  • Price
  • BIOA $4.50
  • CBFV $28.52
  • Analyst Decision
  • BIOA Hold
  • CBFV Hold
  • Analyst Count
  • BIOA 3
  • CBFV 2
  • Target Price
  • BIOA $18.00
  • CBFV $26.00
  • AVG Volume (30 Days)
  • BIOA 233.5K
  • CBFV 11.9K
  • Earning Date
  • BIOA 02-28-2025
  • CBFV 01-29-2025
  • Dividend Yield
  • BIOA N/A
  • CBFV 3.45%
  • EPS Growth
  • BIOA N/A
  • CBFV N/A
  • EPS
  • BIOA N/A
  • CBFV 2.38
  • Revenue
  • BIOA N/A
  • CBFV $50,943,000.00
  • Revenue This Year
  • BIOA N/A
  • CBFV N/A
  • Revenue Next Year
  • BIOA N/A
  • CBFV $9.01
  • P/E Ratio
  • BIOA N/A
  • CBFV $12.26
  • Revenue Growth
  • BIOA N/A
  • CBFV N/A
  • 52 Week Low
  • BIOA $3.85
  • CBFV $20.75
  • 52 Week High
  • BIOA $26.62
  • CBFV $33.72
  • Technical
  • Relative Strength Index (RSI)
  • BIOA N/A
  • CBFV 38.06
  • Support Level
  • BIOA N/A
  • CBFV $29.52
  • Resistance Level
  • BIOA N/A
  • CBFV $30.88
  • Average True Range (ATR)
  • BIOA 0.00
  • CBFV 0.99
  • MACD
  • BIOA 0.00
  • CBFV -0.21
  • Stochastic Oscillator
  • BIOA 0.00
  • CBFV 0.00

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.

About CBFV CB Financial Services Inc.

CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.

Share on Social Networks: